Cigna Corp (CI) Peer Comparison
$273.74
$-0.73
(-0.27%)
As on 22-Sep-2026 16:00EDT
Market cap
$72,930 Mln
Revenue (TTM)
$282,382 Mln
P/E Ratio
11.6
P/B Ratio
1.7
Div. Yield
2.2 %
Edit
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
72,930 | 336,787 | 89,840 | 46,377 | 32,164 |
Revenue ($ Mln) |
282,382 | 450,129 | 201,113 | 145,679 | 193,734 |
Net Profit ($ Mln) |
6,416.00 | 14,122.00 | 4,963.00 | 1,278.00 | -5,099.00 |
Net Margin (%) |
2.27 | 3.14 | 2.47 | 0.88 | -2.63 |
RoE (%) |
13.87 | 13.85 | 11.22 | 6.85 | -23.96 |
Price to Earnings |
11.60 | 24.10 | 18.25 | 36.37 | -- |
Price-To-Book |
1.74 | 3.42 | 1.99 | 2.40 | 1.47 |
Income Statement ($ Mln)
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
282,382.00 | 450,129.00 | 201,113.00 | 145,679.00 | 193,734.00 |
|
Cost of Revenue
|
249,453.00 | 348,915.00 | 122,775.00 | 125,789.00 | 162,493.56 |
|
Gross Profit
|
25,986.00 | 82,917.00 | 50,902.00 | 18,852.00 | 23,833.44 |
|
Operating Expenses
|
23,169.00 | 79,538.00 | 71,276.00 | 17,868.00 | 36,698.81 |
|
Operating Profit (EBIT)
|
9,760.00 | 21,676.00 | 7,062.00 | 2,022.00 | -5,458.38 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
8,451.00 | 17,440.00 | 5,862.00 | 1,614.00 | -4,631.96 |
|
Provision for Tax
|
1,508.00 | 2,528.00 | 915.00 | 298.00 | 474.04 |
|
Profit after Tax (Net Income)
|
6,416.00 | 14,122.00 | 4,963.00 | 1,278.00 | -5,099.00 |
|
Minority Interest
|
-567.00 | -790.00 | 16.00 | -16.00 | 6.00 |
|
Consolidated Profit
|
3,102.00 | 2,358.00 | 1,736.00 | -601.00 | -7,732.00 |
Liabilities ($ Mln)
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
42,620.00 | 98,447.00 | 44,883.00 | 19,213.00 | 22,562.00 |
|
Minority Interest
|
-567.00 | -790.00 | 16.00 | -16.00 | 6.00 |
|
Non-Current Liabilities
|
58,610.00 | 91,958.00 | 48,637.00 | 14,912.00 | 19,596.00 |
|
Current Liabilities
|
55,562.00 | 111,820.00 | 32,779.00 | 23,007.00 | 40,759.00 |
|
Total Liabilities
|
157,919.00 | 309,581.00 | 121,494.00 | 48,750.00 | 77,661.00 |
Assets ($ Mln)
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
110,091.00 | 222,867.00 | 59,254.00 | 17,110.00 | 36,327.00 |
|
Current Assets
|
46,991.00 | 86,860.00 | 67,184.00 | 40,086.00 | 46,685.00 |
|
Total Assets
|
157,919.00 | 309,581.00 | 121,494.00 | 48,750.00 | 77,661.00 |
|
Total Debt*
|
31,878.00 | 73,328.00 | 31,044.00 | 14,247.00 | 16,105.00 |
|
Net Current Assets
|
-8,571.00 | -24,960.00 | 0.00 | 0.00 | 5,926.00 |
Cashflow ($ Mln)
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
9,601.00 | 19,697.00 | 4,290.00 | 921.00 | 5,088.00 |
|
Cash Flow from Investing Activities
|
-4,407.00 | -8,685.00 | -1,344.00 | 2,273.00 | 453.00 |
|
Cash from Financing Activities
|
-6,421.00 | -11,644.00 | -1,738.00 | -1,215.00 | -1,602.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
8.15 | 7.05 | 7.49 | 4.01 | -15.78 |
|
ROE (%)
|
13.87 | 13.85 | 11.22 | 6.85 | -23.96 |
|
ROA (%)
|
3.05 | 3.36 | 2.92 | 1.64 | -4.13 |
|
EBIT Margin (%)
|
2.56 | 4.77 | 3.48 | 1.59 | -2.05 |
|
Net Margin (%)
|
2.27 | 3.14 | 2.47 | 0.88 | -2.63 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
7.75 | 6.46 | 6.27 | 18.33 | 8.72 |
|
EBIT Growth (%)
|
-25.29 | -30.03 | -16.69 | -15.89 | -215.44 |
|
Net Profit Growth (%)
|
27.86 | -33.69 | -7.41 | -18.91 | -348.25 |
|
EPS Growth (%)
|
33.18 | -32.69 | -4.45 | -19.07 | -358.11 |
|
Book Value Growth (%)
|
7.67 | 4.39 | 6.38 | 5.24 | -18.35 |
Valuation Ratios
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
12.29 | 24.92 | 13.73 | 25.94 | -3.03 |
|
Price / Book Value
|
1.75 | 3.19 | 1.77 | 1.75 | 1.01 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
8.27 | 15.21 | 7.83 | 8.20 | -3.63 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.68 | 0.71 | 0.68 | 0.62 | 0.71 |
|
Short term debt to equity ratio
|
0.07 | 0.04 | 0.01 | 0.12 | 0.00 |
|
Current Ratio
|
0.85 | 0.78 | 2.05 | 1.74 | 1.15 |
|
Quick Ratio
|
0.74 | 0.78 | 2.05 | 1.74 | 1.15 |
|
Interest Coverage
|
7.06 | 5.48 | 6.19 | 3.29 | -6.07 |
Operating Efficiency Ratios
| Cigna Corp (CI) | UnitedHealth Group Incorporated (DE) (UNH) | Elevance Health Inc (ELV) | Humana (HUM) | Centene Corp (CNC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
10.91 | 10.28 | 11.63 | 3.91 | 9.33 |
|
Asset Turnover
|
1.34 | 1.07 | 1.18 | 1.87 | 1.57 |
|
Receivable days
|
35.09 | 41.28 | 25.95 | 8.41 | 35.46 |
|
Inventory Days
|
10.29 | -- | -- | -- | -- |
|
Payable days
|
35.52 | 73.09 | 40.45 | 33.09 | 35.85 |
|
Cash Conversion Cycle
|
9.87 | -- | -- | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
